###begin article-title 0
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
Novel LMX1B mutation in familial nail-patella syndrome with variable expression of open angle glaucoma
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
To describe the genetic and clinical findings in a large Spanish pedigree with nail-patella syndrome (NPS) and to investigate the expressivity of open angle glaucoma (OAG) in the family members.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
All individuals underwent a complete ophthalmologic examination, including optical coherence tomography (OCT) of the optic disc and peripapillary region and ultrasound pachymetry. Screening for mutations in the LMX1B gene was performed by denaturing gradient gel electrophoresis and direct genomic sequencing analysis.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
Ten family members had NPS, seven with varying degrees of ocular hypertension (OHT). Only one of these had advanced OAG. The others showed high pachymetry values and OCT retinal nerve fiber layer (RNFL) thickness above the normal values. Screening for mutations in the exonic and flanking sequences of the LMX1B gene showed a deletion of one G (289delG) within the coding sequence of exon 3 at codon 97, resulting in a frame shift that creates a premature stop at codon 105 (E97fsX105), predicting a truncated protein. This mutation was present in all NPS patients and absent in the unaffected family members.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
A novel mutation in the homeobox transcription factor LMX1B causes NPS in a family with variable expressivity of the syndrome, including OAG. The pathogenic mechanism resulting from the mutation is presumably haploinsufficiency rather than a dominant negative effect, which would explain the clinical variability in this family. All NPS OHT patients had considerably thick corneas and RNFL.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
Nail-patella syndrome (NPS; OMIM ), also known as onychoosteodysplasia, Turner-Kieser syndrome, or Fong disease is a rare heterogeneous, autosomal-dominant pleiotropic disorder characterized by skeletal abnormalities such as nail dysplasia and hypoplastic patellae, renal disease, and open-angle glaucoma (OAG) [1-3]. More than 60 mutations in the LMX1B gene have been associated with NPS, which has a high intra- and interfamily degree of heterogeneity [4,5].
###end p 11
###begin p 12
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 372 377 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 484 485 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
The identification of the causative gene for this syndrome, the LIM-homeodomain transcription factor LMX1B, led to investigation of the phenotype and molecular pathogenesis in different target organs in NPS patients [6-8]. The LMX-homeodomain proteins are a family of transcription factors frequently involved in pattern formation during embryonic development [9,10]. The LMX1B gene encodes a transcription factor protein that contains two zinc-binding LIM domains (A and B) at the NH2-terminus and one homeodomain in the middle, which is responsible for the binding to DNA [11-13]. Most of the mutations reported lead to the absence or inactivation of the homeodomain, resulting in a protein unable to recognize its target genes [14,15].
###end p 12
###begin p 13
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 520 523 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 686 694 <span type="species:ncbi:9606">patients</span>
The LMX1B transcription factor protein is involved in normal patterning of the dorsoventral axis of the embryo during development [9,10] and early morphogenesis of the glomerular basement membrane [16]. Molecular studies and genetic immunochemical experiments carried out in the lmx1b-/- mouse model for NPS showed the involvement of lmx1b in the transcription regulation of different alpha chains of type IV collagen in renal podocytes [17,18]. The defect in collagen fibrillogenesis is also seen in the cornea of lmx1b-/- mutant mice, thus supporting the role of LMX1B in collagen regulation. These collagen defects in the eye could be responsible for the presence of glaucoma in NPS patients [19].
###end p 13
###begin p 14
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
NPS is caused by a mutation in the LMX1B gene that presumably leads to loss of function of the encoding transcription factor, and the clinical phenotype is related to the pleiotropic effect of LMX1B during development [20,21]. It has been suggested that as the LMX1B gene encodes a LIM homeodomain transcription factor, which contributes to transcriptional regulation of glomerular membrane collagen expression by podocytes, both renal and ocular malformations could result from the same alteration during embryogenesis.
###end p 14
###begin p 15
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 656 664 <span type="species:ncbi:9606">patients</span>
Many articles have cited the presence of OAG or ocular hypertension (OHT) as one of the features of NPS but the clinical details of this type of glaucoma have never been fully described. Recently, there has been an important advance in glaucoma diagnostic tools with the appearance of new imaging devices of the optic nerve head (ONH) and retinal nerve fiber layer (RNFL), such as optical coherence tomography (OCT) [22]. Moreover, the role of pachymetry in the differential diagnosis of OHT and glaucoma is progressively gaining more importance [23] prior to initiating expensive hypotensive treatments that can cause discomfort and side effects in these patients.
###end p 15
###begin p 16
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
Our study had two aims: (1) to screen a seven-generation NPS Spanish family for mutations in the LMX1B gene; and (2) to characterize the clinical phenotype of their OAG or OHT by performing new structural optic disc examinations such as OCT.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 18
###begin p 19
###xml 44 56 <span type="species:ncbi:9606">participants</span>
###xml 123 128 <span type="species:ncbi:9606">women</span>
###xml 135 138 <span type="species:ncbi:9606">men</span>
###xml 478 486 <span type="species:ncbi:9606">patients</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
###xml 657 664 <span type="species:ncbi:9606">patient</span>
Prior to their inclusion in this study, all participants were informed of its objectives. A total of 18 family members (12 women and 6 men) ranging in age from 7 to 90 years were analyzed. All gave their informed consent to participate in the study, which adhered to the tenets of the Declaration of Helsinki. Affected and unaffected members of a NPS Spanish family underwent a complete ophthalmologic examination and DNA genetic analysis. During the physical examination, some patients mentioned they were receiving topical glaucoma medications. After the initial examination, all patients were scheduled for several follow-up visits over three years. One patient, (IV-1), died a few months after the initial visit before undergoing other tests, such as pachymetry or OCT.
###end p 19
###begin title 20
Molecular genetics
###end title 20
###begin p 21
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 800 801 799 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 803 804 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 817 818 816 817 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 861 866 <span type="species:ncbi:9606">human</span>
Blood samples were drawn for DNA analysis. Genomic DNA was prepared from peripheral blood lymphocytes using QIAmp DNA blood mini kit (Qiagen, Valencia, CA). The coding region of the LMX1B () gene was amplified using primers located in the flanking intron region. Further amplification of exon 3 of LMX1B was carried out using 5'-CTG GGA GGG ACT TCT GAG CA-3' as the forward primer and 5'-CTC CAG GAC ACC CCA GCA AC-3' as the reverse primer. A "CG clamp", consisting of a sequence of 40 CG nucleotides, was included in the 5' sequence of the forward primer, 5'-CCT CCA GGA CAC CCC AGG AA-3', to provide better resolution in the denaturing gradient gel electrophoresis (DGGE) analysis [24]. Polymerase chain reaction (PCR) was performed in a 50 mul volume of buffer (20 mM Tris-HCl, pH 8.55; 16 mM (NH)2SO4; 1.5 mM MgCl2; 150 mug/ml BSA) containing 200-500 ng of human genomic DNA, 25 picomols of each primer, 10 nanomols of each deoxyribonucleoside triphosphate, and 1.5 units of Taq polymerase (Ecotaq). Incubation was performed for 40 cycles consisting of 1 min at 94 degreesC, 1 min at 50 degreesC, and 1 min at 72 degreesC; this was followed by 1 min at 94 degreesC and 5 min at 72 degreesC. Electrophoresis of 8 mul of final PCR reaction volume was performed on 1.5% agarose gel to test the amplification reaction. For DNA sequencing, PCR products were purified using Qiaquick columns (Qiagen). DNA sequencing was carried out using the OpenGene automated DNA sequencing system from Visible Genetics and Thermo Sequenase Cy5.5 Dye Terminator Cycle Sequencing kit (Amersham Pharmacia Biotech, Barcelona, Spain). The sequencing primers were the same as those used for the PCR reaction.
###end p 21
###begin title 22
Eye examination
###end title 22
###begin p 23
###xml 48 55 <span type="species:ncbi:9606">patient</span>
###xml 232 243 <span type="species:ncbi:9606">participant</span>
The personal and family medical history of each patient was critical for determining which individual was affected and for establishing the inheritance pattern. Details about other systemic NPS anomalies were obtained from the each participant's medical chart. A comparison of the severity of systemic manifestations between the family members was performed to establish a spectrum of systemic involvement.
###end p 23
###begin p 24
Best corrected visual acuity (BCVA) was tested with Snellen charts, and ocular refraction was evaluated with an autorefractometer. Biomicroscopy of the anterior segment was performed. Tonometry was done with a Goldmann applanation tonometer, using the mean of three consecutive tonometry readings for each eye. Gonioscopy with a Goldmann three-mirror lens and funduscopy for the observation of the ONH and peripapillary region under direct examination with a 78 D Volkmann lens completed the slit-lamp exam.
###end p 24
###begin title 25
Ancillary examinations
###end title 25
###begin p 26
All cases underwent computerized perimetry with two types of perimeters to confirm the accuracy of the data. We used a 750-Humphrey field analyzer II following a SITA Standard strategy and an Octopus 101 perimeter, TOP strategy. We used a size III stimulus and a white-on-white test for both devices.
###end p 26
###begin p 27
Monoscopic ONH and peripapillary RNFL digital pictures were taken with a Topcon nonmydriatic retinal camera (Topcon model TRC-NW6S, Topcon, Tokyo, Japan).
###end p 27
###begin p 28
Ultrasound pachymetry was performed under topical anesthesia with an Ocuscan RxP pachymeter (Alcon Laboratories Inc., Irvine, CA) that provides six central readings and calculates the mean value. The intraocular pressure (IOP) is then manually introduced in each case and the machine automatically provides a new IOP value corrected for the pachymetry measurements (Herndon Formula).
###end p 28
###begin p 29
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
Optical coherence tomography was performed with OCT version 3 (Stratus OCT, Carl Zeiss Meditec Inc., Dublin, CA), which is a high-resolution cross-sectional imaging technique that allows in vivo measurements of the RNFL (described further in reference [25]). All subjects received pupillary dilatation with 0.5% tropicamide.
###end p 29
###begin p 30
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients underwent three different protocols: fast RNFL thickness, fast ONH, and fast macular thickness measurements. The studied parameters in each protocol (average thickness, superior average thickness, inferior average thickness, vertically integrated rim area, horizontally integrated rim width, cup/disc area ratio, inferior outer macula, and temporal outer macula) were the most relevant for the glaucoma diagnosis according to the study by Medeiros; as all had receiver operating characteristic (ROC) curves above 0.75 except the disc area that was included in our study for demographic purposes [22].
###end p 30
###begin p 31
In all protocols only images with a quality above 7 were accepted. Exams were repeated until this level was reached.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
Genetic analysis
###end title 33
###begin p 34
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 353 361 353 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMXB1</italic>
###xml 1058 1063 1058 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMXB1</italic>
###xml 1070 1071 1070 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 182 189 <span type="species:ncbi:9606">patient</span>
We screened for mutations in all of the exonic and flanking sequences of LMX1B: () in the index case of an NPS family. A DGGE alteration pattern was detected in exon 3 of this index patient but absent in 56 unrelated controls. Direct genomic sequencing revealed the deletion of one G (289delG) within the coding sequence of exon 3 at codon 97 of LMX1B (Figure 1). This nucleotide deletion changes the open reading frame of the gene, creating a premature stop at codon 105 (E97fsX105), presumably giving rise to a truncated protein. Both DGGE analysis and sequencing of exon 3 were carried out in all members of this family. Analysis of the family revealed that several members carried a novel nucleotide change 372 A>G that generates the silent mutation Glu124Glu (data not shown). Because mutations 289delG and 372>G in LMXB1 segregate separately, as deduced by DGGE and sequencing analysis, both mutations would be in separate chromosomes (different alleles). It has been hypothesized that the severity of the NPS may also be related to the second copy of LMXB1 gene [3]. In this large family we cosegregated both alleles (containing the NPS and the silent mutation), but no evidence supporting the hypothesis of a second allele interaction could be found.
###end p 34
###begin p 35
###xml 35 36 35 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 497 498 497 498 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 848 849 848 849 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 887 892 887 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 341 348 <span type="species:ncbi:9606">patient</span>
###xml 350 354 <span type="species:ncbi:9606">VI-4</span>
###xml 778 782 <span type="species:ncbi:9606">VI-4</span>
Genetic results of the NPS family. A: Pedigree of a Spanish family with nail-patella syndrome (NPS). Filled squares and circles denote NPS-affected males and females, respectively. Open squares and circles represent males and females without NPS. A diagonal line through the symbols marks a deceased individual. An arrow indicates the index patient (VI-4). The following symbols were used: wild-type allele (+)2889delG allele (-), and 372A>G allele (x), correspond to a, and allele, respectively. B: Denaturing gradient gel electrophoresis (DGGE) of the PCR fragment of exon 3. The different electrophoretic profiles correspond to carriers of the following: 289delG/WT (IV-1, IV-2, IV-3, V-1, V-2, V-6, and VI-2); WT/372A>G (V-3, VI-1, VI-6, VI-7); 289delG/372A gt G (V-5, V-9, VI-4); WT/WT (V-4, V-8, VI-3) and 372A>G/372A>G (VI-5). WT=wild type. C: DNA genomic sequencing of exon 3 of LMX1B showing the 289delG mutation (left) and a control DNA (right).
###end p 35
###begin p 36
###xml 73 80 73 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 236 244 236 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 264 272 264 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
Ten family members had NPS with varying degrees of systemic involvement (Table 1), although one NPS member died (IV-1) during follow-up. The inheritance pattern was autosomal dominant with complete penetrance but variable expressivity (Figure 1). Onychodysplasia (Figure 2) and patellar hypoplasia were the only signs present in all the patients.
###end p 36
###begin title 37
Systemic phenotype of NPS family.
###end title 37
###begin p 38
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Systemic anomalies of all nail-patella syndrome (NPS) patients evaluated in this study. The following terms were used: F refers to female, M refers to male, OAG is open angle glaucoma, and OHT is ocular hypertension.
###end p 38
###begin p 39
###xml 28 29 28 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 115 116 115 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 102 109 <span type="species:ncbi:9606">patient</span>
###xml 183 190 <span type="species:ncbi:9606">patient</span>
Gonioscopy of NPS patients. A: Color photograph taken during gonioscopy of multiple iris processes in patient V-6. B: Color photograph of a highly pigmented anterior chamber angle of patient V-9.
###end p 39
###begin p 40
###xml 181 189 <span type="species:ncbi:9606">Patients</span>
###xml 198 202 <span type="species:ncbi:9606">VI-4</span>
###xml 231 238 <span type="species:ncbi:9606">patient</span>
###xml 239 243 <span type="species:ncbi:9606">VI-4</span>
###xml 325 333 <span type="species:ncbi:9606">patients</span>
###xml 383 387 <span type="species:ncbi:9606">VI-4</span>
###xml 481 488 <span type="species:ncbi:9606">patient</span>
###xml 509 516 <span type="species:ncbi:9606">patient</span>
Nephropathy (glomerulonephritis) and colon disease (spasmodic colitis) appeared in only a few members. Different skeletal abnormalities were observed in some members of the family: Patients V-5 and VI-4 showed hip subluxation, and patient VI-4 also had generalized joint hyperextensibility, particularly in the fingers. Some patients described generalized muscular pains (V-5, VI-2, VI-4) and chronic fatigue (V-5). The severity of the systemic involvement of NPS was unrelated to patient age, with the index patient being not only the youngest but also one of the most seriously affected.
###end p 40
###begin title 41
Ophthalmologic features
###end title 41
###begin p 42
###xml 330 337 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
Seven of the NPS patients reported having OAG were treated by their ophthalmologists with one or two topical hypotensive drugs. Five of these complained of ocular side effects such as conjunctival hyperemia, itching, iris hyperpigmentation, and eyelash growth. These are well known common side effects of such hypotensive agents (Table 2).
###end p 42
###begin title 43
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Opththalmologic features of NPS patients.
###end title 43
###begin p 44
###xml 427 432 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Ophthalmologic features of all nail-patella syndrome (NPS) patients with either open angle glaucoma or ocular hypertension. The following abbreviations were used: visual acuity (VA), right eye (OD), left eye (OS), light perception (LP), hand motion (HM), baseline intraocular pressure (IOP; in mmHg), pachymetry (PACH; in mum), pachymetry corrected IOP (C IOP), and cup/disc ratio (C/D). The following symbols were used in the LMX1B haplotype column: wild-type allele (+), 2889delG allele (-), and 372A>G allele (x).
###end p 44
###begin p 45
###xml 43 50 <span type="species:ncbi:9606">patient</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 274 281 <span type="species:ncbi:9606">patient</span>
###xml 283 286 <span type="species:ncbi:9606">V-5</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
BCVA was severely diminished in the eldest patient due to diabetic retinopathy with macular edema (IV-1). Two patients with cataracts (IV-2, IV-3) underwent uneventful bilateral phacoemulsification, and their BCVA was unremarkable in the postoperative period. A 48-year-old patient (V-5) presented with mild lens opacities that caused a certain degree of visual loss, suggesting the presence of congenital cataracts. The refractive status of all patients was within the normal range (data not shown).
###end p 45
###begin p 46
###xml 249 258 249 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 383 392 383 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 287 295 <span type="species:ncbi:9606">patients</span>
###xml 586 589 <span type="species:ncbi:9606">V-5</span>
Subjects receiving topical hypotensive medications were asked to stop their medications for a wash-out period of three to four weeks in order to establish a baseline intraocular pressure. Gonioscopy revealed the presence of multiple iris processes (Figure 2A) in the majority of the OAG patients and a highly pigmented trabeculum was also quite common, markedly so in one case (V-9; Figure 2B). No dysplastic changes or presence of abnormal vessels were noticed. All had wide, open anterior chambers and angles measured more than 45degrees, except in one case of 30degreesin both eyes (V-5).
###end p 46
###begin p 47
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 13 16 <span type="species:ncbi:9606">V-1</span>
###xml 184 191 <span type="species:ncbi:9606">patient</span>
###xml 193 197 <span type="species:ncbi:9606">IV-1</span>
One patient (V-1) presented with vertical saucerization in his right ONH and bilateral optic disc asymmetry, defined by a difference greater than 0.2 with left eye cupping. The eldest patient (IV-1) presented with a cup/disc ratio of 0.9, bayoneting of vessels and severe pallor, suggesting advanced glaucoma neuropathy.
###end p 47
###begin p 48
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Ultrasound pachymetry displayed high readings in all NPS patients in contrast with other non-NPS family members who had mean pachymetry readings of 530+/-3 mum.
###end p 48
###begin p 49
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 221 228 <span type="species:ncbi:9606">Patient</span>
###xml 229 232 <span type="species:ncbi:9606">V-5</span>
###xml 523 530 <span type="species:ncbi:9606">Patient</span>
###xml 531 535 <span type="species:ncbi:9606">IV-1</span>
Computerized perimetry was unremarkable in seven patients. Two (IV-2, IV-3) had diffuse decreased sensitivity due to their senile cataracts and presented with normal visual field testings after their cataract extraction. Patient V-5 had an initial inferior arcuate scotomata in both eyes, more marked in her right eye and mild diffuse loss due to congenital lens opacity (Octopus data in decibels (dB): MD 3.7; LV 9.9, OD/MD 2.2, LV 6.4 OS, and Humphrey perimeter data in dB: MD -5.14, DSM 3.57, OD/MD -2.40, DSM 2.09 OS). Patient IV-1 could not perform this test due to her severe low vision.
###end p 49
###begin title 50
Stratus optical coherence tomography data
###end title 50
###begin p 51
###xml 103 110 103 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 429 438 429 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
###xml 303 311 <span type="species:ncbi:9606">patients</span>
The Fast RNFL protocol showed extraordinary high thickness measurements through consecutive OCT tests (Table 3), showing that the peripapillary nerve fiber layer was thicker in these patients than in the normal population (data from 350 controls collected on the hard disk of the OCT machine). Five NPS patients (four with OHT and one normotensive) presented with mean thickness measurements in the "white zone" of the OCT plot (Figure 3A).
###end p 51
###begin title 52
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Stratus optical coherence tomography data of nail-patella syndrome patients.
###end title 52
###begin p 53
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 554 555 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The measurement numbers in red show thickness measurements above the normal range; the rest of the boxes show normal measurements. The following abbreviations were used: retinal nerve fiber layer (RNFL), optic nerve head (ONH) average thickness (AT), superior average thickness (ST), inferior average thickness (IT), vertically integrated rim area (VIRA), horizontally integrated rim width (HIRW), cup/disk area ratio (C/D ratio), inferior outer macula (IOM), and temporal outer macula (TOM). All values are expressed in mm except VIRA (mm3) and HIRW (mm2).
###end p 53
###begin p 54
###xml 55 56 55 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 280 281 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 50 53 <span type="species:ncbi:9606">V-1</span>
###xml 105 112 <span type="species:ncbi:9606">patient</span>
###xml 321 328 <span type="species:ncbi:9606">patient</span>
###xml 329 332 <span type="species:ncbi:9606">V-1</span>
Optical coherence tomography of patients IV-2 and V-1. A: Optical coherence tomography (OCT) diagram for patient IV-2 in which above-normal retinal nerve fiber layer (RNFL) thickness measurements are expressed in white in the pie chart. Green sectors are within the normal range. B: OCT Fast optic nerve head protocol of patient V-1, confirming cup enlargement.
###end p 54
###begin p 55
###xml 148 157 148 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 135 142 <span type="species:ncbi:9606">patient</span>
###xml 165 172 <span type="species:ncbi:9606">patient</span>
The Fast ONH protocol provided measurements of optic disc and cup diameters, volumes, and ratios that were also unremarkable except in patient V-I (Figure 3B). This patient presented with a pathologic cup/disc (C/D) area ratio in his OD (0.8) and bilateral asymmetry above 0.2 (C/D ratio 0.6 OS).
###end p 55
###begin p 56
###xml 83 91 <span type="species:ncbi:9606">patients</span>
The Fast macular thickness protocol provided completely normal results for all the patients.
###end p 56
###begin title 57
Glaucoma therapeutic approach
###end title 57
###begin p 58
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient IV-I had been previously diagnosed with severe OAG based on tonometry and optic disc aspect and was under treatment with two drugs until she died.
###end p 58
###begin p 59
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients IV-2 and IV-3 were diagnosed with OHT or preperimetric OAG, and their topical hypotensive drugs were stopped. They presented normal perimetry and OCT at follow-up examinations after bilateral phacoemulsification.
###end p 59
###begin p 60
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 8 11 <span type="species:ncbi:9606">V-1</span>
Patient V-1 was diagnosed with glaucoma suspect upon optic nerve asymmetry between both eyes, confirmed by the C/D area ratio provided by OCT. He is being treated with one hypotensive drug (prostaglandin analog nightly).
###end p 60
###begin p 61
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 41 45 <span type="species:ncbi:9606">VI-4</span>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Patient V-2 and her two daughters (VI-2, VI-4) were considered as non-OHT NPS patients.
###end p 61
###begin p 62
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 8 11 <span type="species:ncbi:9606">V-5</span>
Patient V-5 was deemed to have glaucoma based on the IOP readings and initial arcuate perimetry lesions, although the optic nerves were not apparently affected according to their aspect and the OCT. She is currently receiving hypotensive treatment with a prostaglandin analog and, as she is developing cataracts, will be scheduled for phacoemulsification.
###end p 62
###begin p 63
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients V-6 and V-9 were diagnosed with OHT because their IOPs were above 20 mmHg but less than 30 mmHg. Their ophthalmologic explorations were otherwise unremarkable. They currently remain without treatment.
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
We screened an index case from a large Spanish family with NPS for mutations in the LMX1B gene and found a novel nonsense mutation, 289delG, causing a premature stop at codon 105 (E97fsX105). The mutation is located in exon 3 of LMX1B, which encodes the COOH-terminal region of the LIM-A domain. Thus, in the putative-encoded mutant protein, the lack of the LIM-B domain and the homeodomain (HD) probably impede the DNA binding capacity of the protein.
###end p 65
###begin p 66
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 188 196 <span type="species:ncbi:9606">patients</span>
To date, more than 60 point mutations, small deletions, or insertions have been reported, clustered in the LIM and HD domains of the LMX1B gene [14,15,20,21]. However, no mutations in NPS patients have been detected in the COOH-terminal third of the coding sequence of the LMX1B gene, suggesting that mutations in this region are not inactivating [15]. Furthermore, transfection studies performed with NPS mutants showed no significant dominant-negative effect on the function of the wild-type LMX1B [21,26]. These findings support haploinsufficiency as the mechanism underlying pathogenesis of NPS [20,21,27].
###end p 66
###begin p 67
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 183 190 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
Mutations in LMX1B associated with NPS result in skeletal defects. All family members in this study who carried the E97fsX105 mutation showed nail dysplasia and hypoplastic patellae (Table 1), and most of them also had other skeletal abnormalities. These common features were present with almost complete penetrance in the family. Some typical characteristics were present at an early age, with members of the family being able to predict who were carriers of the disease. Indeed, their predictions agreed with our results concerning the carriers of the mutation in the LMX1B gene. However, renal, gastrointestinal, or ophthalmic involvement was more variable within the family.
###end p 67
###begin p 68
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lmx1b</italic>
###xml 297 299 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 300 302 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 428 430 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 491 496 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lmx1b</italic>
###xml 581 586 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lmx1b</italic>
###xml 699 701 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 702 704 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 752 757 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lmx1b</italic>
###xml 757 760 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/-</sup>
###xml 831 836 823 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lmx1b</italic>
###xml 1003 1008 995 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 1044 1049 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 416 422 <span type="species:ncbi:10090">murine</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 860 866 <span type="species:ncbi:9606">humans</span>
###xml 909 917 <span type="species:ncbi:9606">patients</span>
###xml 1148 1156 <span type="species:ncbi:9606">patients</span>
The expression of LMX1B in the kidney occurs exclusively in podocytes [18]. Studies carried out in lmx1b knockout mice that mimic NPS showed an important impairment of the glomerular basement membrane with expression of the alpha3 and alpha4 chains of collagen IV and severe reduction of podocin [18,19]. Importantly, lmx1b is also necessary for normal development of multiple tissues in the anterior segment of the murine eye [19] Abnormalities in collagen fibrils in the corneal stroma of lmx1b knockout mice have been observed. The abnormal expression of collagen in homozygous lmx1b knockout mice may explain the split in the glomerular basement membrane in the kidney or the eye abnormalities [18,19] possibly related with glaucoma. Surprisingly, lmx1b+/- mice do not show an abnormal phenotype, indicating differences in the lmx1b gene doses compared to humans. Recent immunohistological studies in NPS patients with severe glomerular disease suggest a possible regulation of type III collagen by LMX1B, while the homozygous mutations of LMX1B do not appear to dramatically affect the expression of type IV collagen chains and podocin in NPS patients.
###end p 68
###begin p 69
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 857 858 857 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 291 296 <span type="species:ncbi:10090">mouse</span>
###xml 607 612 <span type="species:ncbi:10090">mouse</span>
###xml 691 699 <span type="species:ncbi:9606">patients</span>
Several well-known NPS studies have reported cosegregation of OAG and NPS as a result of a pleiotropic effect of the LMX1B gene in different families [1-3,14]. None of these studies described the glaucomatous features in detail. Some ocular abnormalities have been described in the knockout mouse model [19] such as an abnormal keratocan expression in the cornea, abnormal collagen fibrillogenesis, and a reduction in the depth of the anterior chamber. The LMX1B gene is also expressed in the trabecular meshwork but abnormalities in this tissue were not analyzed due to the short life span of the knockout mouse. In addition, many other ocular anomalies have been found sporadically in NPS patients, including microcornea, sclerocornea, congenital cataracts, iris processes, and pigmentation of the inner margin of the iris (referred to as Lester's sign) [1], but none of these is a specific trait of this syndrome.
###end p 69
###begin p 70
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 445 447 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 770 771 768 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 919 920 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 1105 1110 1103 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
Sweeney et al. [5] provided data from 123 NPS patients, most of whom were visited at home. IOP was measured using a Tonopen(R) and patients with IOP readings higher than 21 mmHg were advised to seek an ophthalmologist for further investigation. The researchers reported a prevalence of glaucoma and OHT of 9.6% and 7.2%, respectively. No other additional information of note for a glaucoma diagnosis is available in their study. Bongers et al. [27] gave more reliable information. In their study, patients underwent gonioscopy and Humphrey visual field analysis. They found glaucoma and OHT in 35.3% of the patients and reported other ocular anomalies, such as corneal anomalies, iris pigmentation, pigment dispersion syndrome, and congenital cataracts. Lichter et al. [1] reported OAG in 13 of 33 families, some of whom had IOP higher than 30 mmHg and required filtration surgery. Recently, a large study by Mimiwati [2] found glaucoma in 11.1% of his NPS population (33% of cases over the age of 40 years) and OHT in 11.1%. They reported an average age at diagnosis of glaucoma in cases with apparently LMX1B causative mutations of 29.7 years, which is substantially below the expected age at diagnosis for most cases of primary OAG. The authors performed a comprehensive glaucoma screening that included IOP, automated perimetry, and stereo disc photographs on all available family members.
###end p 70
###begin p 71
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
New imaging techniques, such as OCT, are becoming useful tools for the structural analysis of the optic disc and peripapillary region, target sites of glaucomatous damage. The most useful protocols are the Fast RNFL thickness and Fast ONH, and several OCT parameters are presently being used to evaluate the presence of glaucomatous optic disc damage [22].
###end p 71
###begin p 72
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 426 433 <span type="species:ncbi:9606">patient</span>
###xml 434 437 <span type="species:ncbi:9606">V-5</span>
###xml 478 485 <span type="species:ncbi:9606">patient</span>
###xml 601 608 <span type="species:ncbi:9606">patient</span>
###xml 610 613 <span type="species:ncbi:9606">V-1</span>
This is the first report of OCT data in NPS patients with glaucoma or OHT. Surprisingly, all our study patients presented RNFL thickness measurements above normal. This indicates that there is no loss of peripapillary nerve fiber bundles and thus excludes the presence of glaucomatous optic neuropathy in our study population. These data correlated well with the aspect of the optic disc and the perimetric results, except in patient V-5, who presented arciform scotomata. This patient requires future perimetry testing after phacoemulsification, as the cataract could skew the perimetry results. One patient (V-1) presented with marked optic disc cupping according to the examiner's subjectivity; it was supported by the ONH OCT protocol.
###end p 72
###begin p 73
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Pachymetry-measured central corneal thickness has a significant effect on the clinical management of patients with glaucoma and glaucoma suspects [28]. In 1970, Ehlers [29] published a paper suggesting that corneal thickness, another biomechanical measurement of the eye, also affected IOP. Technology to measure corneal thickness has developed over time, and it was not until the publication of the Ocular Hypertension Treatment Study (OHTS) [23] in 2002 that central corneal thickness (CCT) was suggested to be an independent risk factor for progression to initial glaucoma damage among individuals with OHT.
###end p 73
###begin p 74
###xml 396 398 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1105 1113 <span type="species:ncbi:9606">patients</span>
A thin pachymetry reading under 530 mum is considered a risk factor for developing glaucoma in eyes with OHT. Recent general practice guidelines recommend performing routine pachymetry and applying a correction factor to the IOP measurements in order to avoid a confounding effect. An association has even been proposed between CCT and the elasticity of the lamina cribrosa. A very recent study [30] even suggested an inverse correlation between CCT and optic disc area. While thicker corneas may cause examiners to make a slight overestimation of true IOP, their thickness may also indicate the presence of a substantially smaller, and thus more robust, ONH. Conversely, individuals with thinner corneas, which may initiate a slight underestimation of true IOP, may also be those with larger and more deformable optic discs. Our study population corroborated this fact: All presented with thick corneas and thick RNFL measurements whereas non-NPS family members had "normal" CCTs. Whether thick CCT belongs to the constellation of NPS traits is still unknown and requires routine pachymetry in all these patients.
###end p 74
###begin p 75
###xml 209 211 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
Our study population had OHT that fell within "normal" limits of IOP readings after the automated pachymetry corrections performed by the Ocuscan(R), as they all had very thick corneas. According to the OHTS [23], they all have a low risk of developing OAG in the future. Moreover, their functional and structural tests were normal, and medical treatment was not required in these cases. It was actually withdrawn in several cases except those with suspected glaucoma. We do not know if any other NPS glaucoma cases described in the literature would have OHT or possible glaucoma after pachymetry IOP correction.
###end p 75
###begin p 76
###xml 218 226 <span type="species:ncbi:9606">patients</span>
The role that iris processes play in the development of OHT is unknown, as they have classically been considered to be innocuous, unlike the presence of high trabecular pigmentation. Almost all our OHT and non-OHT NPS patients had a myriad of iris processes in their anterior chamber angles. This trait, therefore, seems to accompany the other NPS manifestations, as has been described before, and is independent of IOP.
###end p 76
###begin p 77
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
###xml 485 492 <span type="species:ncbi:9606">patient</span>
###xml 538 545 <span type="species:ncbi:9606">patient</span>
In the family reported, some patients had OHT and kidney or colon abnormalities. The 30% proportion of the family who had gastrointestinal and renal abnormalities of NPS is similar to previously reported data. The presence of glaucoma or OHT has been estimated to be near 30% in other studies, but in this family 70% of the NPS patients had OHT, indicating that this is a significant feature in the family. OHT was not a constant sign and its severity did not depend on the age of the patient or the degree of systemic disease. The index patient in this family was one of the most affected individuals, with severe skeletal anomalies and nephropathy, though she did not have OHT.
###end p 77
###begin p 78
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMX1B</italic>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
We conclude that NPS shows a high inter- and intrafamily heterogeneity. The pathogenesis of OAG or OHT in these patients is still not well understood, and it shows no correlation with the severity of other systemic anomalies. OHT was not present in unaffected individuals, and it seems to be a genuine pleiotropic effect of the LMX1B mutation in this family.
###end p 78
###begin p 79
###xml 68 75 <span type="species:ncbi:9606">persons</span>
###xml 344 352 <span type="species:ncbi:9606">patients</span>
Caution should be taken when diagnosing the presence of glaucoma in persons with NPS, and it should be corrected by pachymetry. OCT is a useful tool for the diagnosis of glaucomatous optic nerve and RNFL pathology, especially in those cases with unclear perimetric testing. We encourage other investigators to perform pachymetry and OCT in NPS patients in order to corroborate the presence of a higher thickness of the corneal and retinal nerve tissues. Surprisingly both factors could, in a certain way, be considered as "protective" ocular mechanisms against the presence of glaucomatous optic nerve damage. There is still a long way to go in the establishment of a correlation between glaucoma and other ocular manifestations of this syndrome, such as the presence of multiple iris processes. Ultrastructural studies are needed to establish whether both renal and ophthalmic anomalies belong to the same form of inheritable connective tissue disorder.
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
The authors thank Ian Johnstone for editorial assistance.This work was partially supported by grants from Fondo de Investigacion Sanitaria (Spanish government and European Union funds) FIS (01/0081-01, 02/0474, G03/018).
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
Cosegregation of open-angle glaucoma and the nail-patella syndrome.
###end article-title 83
###begin article-title 84
Nail-patella syndrome and its association with glaucoma: a review of eight families.
###end article-title 84
###begin article-title 85
An orthopaedic scoring system for nail-patella syndrome and application to a kindred with variable expressivity and glaucoma.
###end article-title 85
###begin article-title 86
Nail-patella syndrome: identification of mutations in the LMX1B gene in Dutch families.
###end article-title 86
###begin article-title 87
Nail patella syndrome: a review of the phenotype aided by developmental biology.
###end article-title 87
###begin article-title 88
Fine mapping of the nail-patella syndrome locus at 9q34.
###end article-title 88
###begin article-title 89
Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome.
###end article-title 89
###begin article-title 90
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome.
###end article-title 90
###begin article-title 91
Induction of the LIM homeobox gene Lmx1 by WNT7a establishes dorsoventral pattern in the vertebrate limb.
###end article-title 91
###begin article-title 92
###xml 30 35 <span type="species:ncbi:9031">chick</span>
Dorsal cell fate specified by chick Lmx1 during vertebrate limb development.
###end article-title 92
###begin article-title 93
The LIM domain: a new structural motif found in zinc-finger-like proteins.
###end article-title 93
###begin article-title 94
Molecular dissection of a LIM domain.
###end article-title 94
###begin article-title 95
The LIM/double zinc-finger motif functions as a protein dimerization domain.
###end article-title 95
###begin article-title 96
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Mutation analysis of LMX1B gene in nail-patella syndrome patients.
###end article-title 96
###begin article-title 97
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Restricted distribution of loss-of-function mutations within the LMX1B genes of nail-patella syndrome patients.
###end article-title 97
###begin article-title 98
Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome.
###end article-title 98
###begin article-title 99
Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation.
###end article-title 99
###begin article-title 100
The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes.
###end article-title 100
###begin article-title 101
###xml 140 146 <span type="species:ncbi:10090">murine</span>
LMX1B, a LIM homeodomain class transcription factor, is necessary for normal development of multiple tissues in the anterior segment of the murine eye.
###end article-title 101
###begin article-title 102
Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome.
###end article-title 102
###begin article-title 103
Functional characterization of LMX1B mutations associated with nail-patella syndrome.
###end article-title 103
###begin article-title 104
Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography.
###end article-title 104
###begin article-title 105
Corneal thickness in glaucoma screening, diagnosis, and management.
###end article-title 105
###begin article-title 106
Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.
###end article-title 106
###begin article-title 107
Optical coherence tomography.
###end article-title 107
###begin article-title 108
LMX1B transactivation and expression in nail-patella syndrome.
###end article-title 108
###begin article-title 109
Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy.
###end article-title 109
###begin article-title 110
Clinical significance of central corneal thickness in the management of glaucoma.
###end article-title 110
###begin article-title 111
On corneal thickness and intraocular pressure. II. A clinical study on the thickness of the corneal stroma in glaucomatous eyes.
###end article-title 111
###begin article-title 112
Central corneal thickness and correlation to optic disc size: a potential link for susceptibility to glaucoma.
###end article-title 112

